The fourth quarter of 2019 was eventful, and we had the opportunity to see progress
in several areas. Importantly, we closed a rights issue of SEK 43 million, before
transaction costs, securing our ability to execute our plans and activities moving
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.